Navigation Links
Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials
Date:6/4/2011

or sites of disease involvement.  The study was lead by Minetta Liu, M.D., Georgetown Lombardi Comprehensive Cancer Center and will be presented during a poster session on Monday, June 6th, 2011.

Dr. Minetta Liu has provided consulting services to the company. 

About Circulating Tumor Cells

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream.  The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.

About CELLSEARCH® CTC Test

CELLSEARCH® is the first and only regulatory-cleared in vitro diagnostic test to capture and count CTCs to determine the prognosis of patients with metastatic breast, colorectal or prostate cancer.  The test can be administered at any time during the course of therapy as a routine blood test.  It is used in combination with other tests and a clinician's assessment, to provide a more complete picture of a patient's prognosis.

About Veridex, LLC

Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians with high-value diagnostic oncology products.  Veridex's IVD products may significantly benefit patients by helping physicians make more informed decisions that enable better patient care.  Veridex's Clinical Research Solutions provide tools and services that may be used for the selection, identification and enumeration of targeted rare cells in peripheral blood for the identification of biomarkers, aiding scientists in their search for new, targeted therapies.  For more information, visit www.veridex.com

About Abiraterone

In the U.S., abiraterone acetate is marketed as ZYTIGA™ by
'/>"/>

SOURCE Veridex, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
2. American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA
3. American Stroke Association Late-Breaking Science Report: Antiplatelet Drug May Be Better Than Aspirin in Preventing Recurrent Strokes
4. American Heart Association Late-Breaking Clinical Trial Report: New Reversible Oral Drug Reduces Cardiac Events in Primary PCI Patients
5. American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis
6. MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
7. MAP Pharmaceuticals Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
8. Impulse Dynamics Announces Pivotal Results at the American College of Cardiology Annual Meeting Late-Breaking Session
9. Results From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session
10. Atritech to Participate in Late-Breaking Clinical Trial Presentation at American College of Cardiology Meeting
11. Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... -- Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy ... clinics opened in Memphis and ... added in Springfield on September 24 and ... to open October 22.  MinuteClinic is the largest and fastest growing ... . The Memphis -area clinics ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
(Date:9/19/2014)... 2014 Intarcia Therapeutics, Inc. today ... its lead candidate ITCA 650 (continuous subcutaneous delivery of ... HbA1c levels at the 50 th Annual Meeting ... (EASD). Data from the open-label, phase 3 FREEDOM-HBL (high ... in patients with poorly controlled type 2 diabetes. The ...
Breaking Medicine Technology:MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... DIEGO, March 14, 2012 OncoSec Medical ... OncoSec Medical System (OMS) ElectroOncology therapies to treat ... Cancer Institute in Santa Monica, CA, and Lakeland ... initiated as enrolling sites, and investigators are screening ...
... YORK, March 14, 2012 Reportlinker.com ... report is available in its catalogue: ... Market Outlook in BRICS (Brazil, Russia, ... http://www.reportlinker.com/p0796126/Respiratory-Devices-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Respiratory_Devices ...
Cached Medicine Technology:OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 2Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 3Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 4Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 5Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 6Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 7Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 8Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 9Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 10Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 11Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 12Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 13Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 14Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 15Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 16Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 17Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 18Respiratory Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017 19
(Date:9/20/2014)... September 21, 2014 6 Minutes to ... fitness expert Craig Ballantyne that is showing men and women ... blast away stubborn body fat using simple 6-minute exercises and ... Michaels, prompting an investigative review. , “When it comes ... in vs. calories out for all people,” reports Michaels. “Metabolism ...
(Date:9/20/2014)... Melbourne, Australia (PRWEB) September 21, 2014 ... levels are contributing to greater waste treatment volumes. ... are increasingly diverting waste from landfill. According to ... decade, governments have implemented strategies aimed at reducing ... amount of waste recycled and recovered.” Still, a ...
(Date:9/20/2014)... September 20, 2014 As testosterone ... in federal court, Bernstein Liebhard LLP notes that ... (FDA) have voted overwhelmingly to recommend that prescription ... be subjected to further study in order to ... published on September 18th by Bloomberg.com, the panel ...
(Date:9/20/2014)... Sept. 20, 2014 (HealthDay News) -- As flu season ... infection is to get a flu shot and a ... A primary care doctor can vaccinate people against the ... patients may have. Retail stores may provide flu shots ... advice, said Dr. Jorge Parada, medical director of infection ...
(Date:9/20/2014)... York (PRWEB) September 20, 2014 ... ( http://www.injurybeacon.com/power-morcellator/ ) in gynecological surgeries continue ... another insurer has announced plans to end coverage ... on its website last month, Harrisburg, Pennsylvania-based Capital ... November 1, 2014. The insurer said its decision ...
Breaking Medicine News(10 mins):Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 2Health News:As Testosterone Lawsuits Grow, Bernstein Liebhard LLP Notes Overwhelming Vote Calling for Further Study of Testosterone Heart Risks 3Health News:Get a Flu Shot During Checkup, Doctor Says 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3
... of MRSA that causes bloodstream infections is five times more ... resistance to the potent antibiotic drug vancomycin used to treat ... study found that 50 percent of the patients infected with ... of patients infected with other MRSA strains. The ...
... During Last Year,s ,One Million Tests, World AIDS Day ... Testing Goal by Testing 35,034 , PHNOM PENH, Cambodia, ... to test several million people for HIV in observance of ... 2009 campaign, AHF/Cambodia CARES will launch its inaugural testing effort ...
... be reserved for the most seriously ill, experts say , ... to fight anemia appears to double the risk of stroke ... their quality of life, a new study finds. , ... agent (ESA), is often prescribed for diabetic patients with chronic ...
... Oct. 30 Amgen (Nasdaq: AMGN ) today ... to Reduce Cardiovascular Events with Aranesp® Therapy), a large, ... with chronic kidney disease (CKD) not on dialysis, moderate ... in the New England Journal of Medicine ...
... Beach, CA; December 8, 2009 , NEEDHAM, Mass., Oct. ... a special event, Terminology Services Information Day, will be co-located ... on December 8, 2009. For more information and to register ... . , (Logo: http://www.newscom.com/cgi-bin/prnh/20090629/DC39325LOGO ...
... Oct. 30 A hospital group based in McAllen, ... to settle claims that it violated the False Claims Act, ... 2006, by paying illegal compensation to doctors in order to ... the Justice Department announced today. McAllen Hospitals L.P., d/b/a/ South ...
Cached Medicine News:Health News:Henry Ford Hospital study: A MRSA strain linked to high death rates 2Health News:Cambodia: World AIDS Day HIV Campaign, 'Testing Millions,' to Again Launch During Cambodia's National Water Festival 2Health News:Anemia Drug May Raise Stroke Risk in Kidney Patients 2Health News:Anemia Drug May Raise Stroke Risk in Kidney Patients 3Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 2Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 3Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 4Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 5Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 6Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 7Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 8Health News:Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints 9Health News:OMG Announces Special Event: Terminology Services Information Day 2Health News:OMG Announces Special Event: Terminology Services Information Day 3Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 2Health News:Texas Hospital Group Pays U.S. $27.5 Million to Settle False Claims Act Allegations 3
... Inserted into the punctal opening to ... collagen plugs provide temporary relief of ... precisely measured premium collagen, Used as ... occlusion, Available in standard and short ...
... head combined with a softer more flexible ... design simplifies insertion and the large anchor ... dislocation less likely. The inserter provides ... SOFT PLUG Silicone Plugs are removable. Available ...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain CS Leads. Navigate minimally angled veins with no tortuosity....
Medicine Products: